| Literature DB >> 31036683 |
Karryn Gresty1,2, Karen Anderson1,2, Cielo Pasay1,3, Norman C Waters4, Qin Cheng5,2.
Abstract
The South Pacific countries Solomon Islands, Vanuatu, and Papua New Guinea (PNG) adopted artemisinin-based combination therapies (ACTs) in 2008. We examined Kelch 13 and Kelch 12 genes in parasites originating from these countries before or at ACT introduction. Four Kelch 13 and two Kelch 12 novel sequence polymorphisms, not associated with artemisinin resistance, were observed in parasites from Solomon Islands and Vanuatu. No polymorphisms were observed in PNG parasites. The findings provide useful baseline information.Entities:
Keywords: Kelch 12; Kelch 13; P. falciparumzzm321990; artemisinin combination therapy; artemisinin resistance; sequence polymorphism
Year: 2019 PMID: 31036683 PMCID: PMC6591608 DOI: 10.1128/AAC.00536-19
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191